Smart Immune is a biotech company that helps fight against cancer and infection by providing a thymus-empowered T-cell therapy platform.
Smart Immune has raised $5.0M in total funding. The most recent round was Grant. The last funding was announced in April 2023.
Smart Immune's investors include Bill & Melinda Gates Foundation, European Innovation Council, Sebastian Lombardo.
Smart Immune is headquartered in Paris, France.
Smart Immune is a biotech company that helps fight against cancer and infection by providing a thymus-empowered T-cell therapy platform.
Smart Immune is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Smart Immune — Funding & Investors." VCBacked, April 16, 2023, https://www.vcbacked.co/company/smart-immune. Accessed August 14, 2026.
VCBacked. (2023). Smart Immune — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/smart-immune
{{cite web |title=Smart Immune — Funding & Investors |url=https://www.vcbacked.co/company/smart-immune |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated